According to the Zhitong Finance App, Junshengtai Pharmaceutical-B (02511) announced the allotment results. The company sold 24.194 million shares globally, accounting for 30% of the public offering, accounting for 30%, and international sales accounting for 70%. The final offering price was HK$11.5 per share, with a net global offering of approximately HK$194 million. Each lot is 500 shares. It is expected that the shares will begin trading on the Stock Exchange at 9:00 a.m. on December 22, 2023.

Among them, the public sale received 32.22 times more subscriptions, triggering a reimbursement mechanism. International sales received 1.25 times more subscriptions.